|
Volumn 2, Issue 10, 2001, Pages 1375-1377
|
The treatment of pulmonary aspergilloma
|
Author keywords
Antifungal therapy; Aspergilloma; Aspergillus; Itraconazole; Pulmonary diseases; Thoracic surgery
|
Indexed keywords
AMPHOTERICIN B;
ANTIFUNGAL AGENT;
IMMUNOGLOBULIN G;
ITRACONAZOLE;
PLACEBO;
ARTIFICIAL EMBOLISM;
ASPERGILLUS FUMIGATUS;
BRONCHIAL ARTERY;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
DISEASE SEVERITY;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG PENETRATION;
HEMOPTYSIS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE DEFICIENCY;
INJECTION;
LUNG ASPERGILLOSIS;
LUNG SARCOIDOSIS;
PROGNOSIS;
REVIEW;
RISK FACTOR;
THORAX SURGERY;
TOXICITY;
TREATMENT OUTCOME;
ANIMALS;
ANTIFUNGAL AGENTS;
ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY;
BRONCHIAL ARTERIES;
COMBINED MODALITY THERAPY;
EMBOLIZATION, THERAPEUTIC;
HUMANS;
ITRACONAZOLE;
RISK FACTORS;
|
EID: 0034781814
PISSN: 09678298
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (39)
|
References (32)
|